Wize Pharma, Inc. | Business Contracts

Securities Purchase Agreement dated August 6, 2021 (Filed With SEC on November 15, 2021)

Electricity Supply Agreement between MIG No.1 Pty Ltd and Cape Byron Management Pty Ltd dated October 22, 2021 (Filed With SEC on October 22, 2021)

Employment Agreement between Mawson Infrastructure Group Pty Ltd and Nicholas Hughes-Jones dated October 8, 2021 (Filed With SEC on October 8, 2021)

Lease Agreement between Mawson Infrastructure Group and Jewel Acquisition, LLC dated September 20, 2021 (Filed With SEC on September 21, 2021)

Resignation letter of Or Eisenberg (Filed With SEC on August 20, 2021)

Amendment to License Agreement with Resdevco Research and Development Company Ltd (Filed With SEC on November 14, 2019)

Joint Venture Agreement (Filed With SEC on February 12, 2019)

Form of Compensation Warrant (Filed With SEC on October 1, 2021)

Form of Warrant Agreement (Filed With SEC on October 1, 2021)

Underwriting Agreement, dated September 28, 2021, by and between Mawson Infrastructure Group Inc., and H.C. Wainwright & Co., LLC (Filed With SEC on October 1, 2021)

Second Amendment to Lease Agreement between Luna Squares LLC and The Development Authority of Washington County dated August 24, 2021 (Filed With SEC on August 30, 2021)

Employment Agreement of Hetal Majithia dated August 19, 2021 (Filed With SEC on August 20, 2021)

International Sales Contract No. ZY0220211229 between Mawson Infrastructure Group Pty Ltd and Canaan Convey Co. Ltd (Filed With SEC on August 12, 2021)

Employment Agreement between Mawson Infrastructure Group Inc. and Liam Daniel Wilson (Filed With SEC on August 12, 2021)

Form of Securities Purchase Agreement dated August 6, 2021 (Filed With SEC on August 10, 2021)

Amendment to Convertible Loans Agreements dated November 29, 2019 (Filed With SEC on July 27, 2021)

Amendment to Exclusive Distribution and Licensing Agreement by and between Wize Pharma Ltd., OcuWize Ltd. and Resdevco Research and Development Company Ltd., dated May 4, 2020 (Filed With SEC on July 27, 2021)

Membership Interest Purchase Agreement dated July 6, 2021 between Mawson Infrastructure Group Inc. and TRS Ventures LLC (Filed With SEC on July 9, 2021)

Membership Interest Purchase Agreement dated July 5, 2021 between Mawson Infrastructure Group Inc. and Kyle Hoffman (Filed With SEC on July 9, 2021)

Warrants issued to W Capital Advisors Pty Limited (Filed With SEC on June 9, 2021)

Warrant issued to HC Wainwright (Filed With SEC on June 9, 2021)

Form of February 2021 Convertible Note (Filed With SEC on June 9, 2021)

Second Amendment To The Equipment Finance And Security Agreement Dated April 1, 2021 (Filed With SEC on May 19, 2021)

Amendment To The Equipment Finance And Security Agreement Dated February 5, 2021 (Filed With SEC on May 19, 2021)

Equipment Purchase and Finance and Security Agreement with Foundry Digital LLC (Filed With SEC on May 19, 2021)

International Sales Contract NoZY0220211163 between Cosmos Infrastructure LLC and Canaan Convey Co., Ltd. dated March 26, 2021 (Filed With SEC on May 19, 2021)

International Sales Contract No:ZY0220211061 between Cosmos Infrastructure LLC and Canaan Convey Co., Ltd. dated February 5, 2021 (Filed With SEC on May 19, 2021)

First Amendment to Lease Agreement and Exercise of Option to Lease an Additional Four Adjoining Acres between Luna Squares LLC (FKA Innovative Property Management, LLC) and The... (Filed With SEC on May 19, 2021)

Lease Agreement between Luna Squares LLC (FKA Innovative Preperty Management, LLC) and The Development Authority of Washington County dated May 1, 2020 (Filed With SEC on May 19, 2021)

Description of Securities (Filed With SEC on March 1, 2021)

Amendment to Exclusive Distribution and Licensing Agreement by and between Wize Pharma Ltd., OcuWize Ltd. and Resdevco Research and Development Company Ltd., dated May 4, 2020 (Filed With SEC on March 1, 2021)

Form of Contingent Value Rights Agreement (Filed With SEC on January 19, 2021)

Form of Stock Restriction Agreement (Filed With SEC on January 19, 2021)

Deed of Amendment, dated January 18, 2021, of the Bid Implementation Agreement between Wize Pharma, Inc. and Cosmos Capital Limited, dated December 30, 2020 (Filed With SEC on January 19, 2021)

Securities Purchase Agreement, between Wize Pharma, Inc. and Noam Danenberg, dated December 30, 2020 (Filed With SEC on January 5, 2021)

Form of Securities Purchase Agreement, between Wize Pharma, Inc. and various Purchasers, dated December 30, 2020 (Filed With SEC on January 5, 2021)

Form of Contingent Value Rights Agreement (Filed With SEC on January 5, 2021)

Form of Warrant Agency Agreement (Filed With SEC on January 5, 2021)

Bid Implementation Agreement, between Wize Pharma, Inc. and Cosmos Capital Limited, dated December 30, 2020 (Filed With SEC on January 5, 2021)

Addendum Agreement, between Wize Pharma, Inc. and Bonus BioGroup Ltd., dated November 29, 2020 (Filed With SEC on November 30, 2020)

Form of Amendment No. 1, dated as of October 28, 2020, to the Securities Purchase Agreement of October 22, 2018, by and among the Company and the investors signatory thereto (Filed With SEC on November 16, 2020)

Amendment to Letter Agreement (SPA), dated July 1, 2020, by and between the Company and Bonus BioGroup Ltd (Filed With SEC on August 14, 2020)

Letter Agreement (SPA), dated June 24, 2020, by and between the Company and Bonus BioGroup Ltd (Filed With SEC on August 14, 2020)

Description of Securities (Filed With SEC on March 30, 2020)

Memorandum of Understanding between Wize Pharma Ltd. and Resdevco, Research and Development Ltd. dated February 24, 2019 (Filed With SEC on March 30, 2020)

Share Purchase Agreement by and between Bonus BioGroup Ltd. and Wize Pharma Inc., dated January 9, 2020 (Filed With SEC on January 15, 2020)

Form of Registration Rights Agreement (Filed With SEC on January 15, 2020)

Exchange Agreement by and between Bonus BioGroup Ltd. and Wize Pharma Inc., dated January 9, 2020 (Filed With SEC on January 15, 2020)

Series B Purchase Agreement by and between Wize Pharma Inc. and various investors, dated January 9, 2020 (Filed With SEC on January 15, 2020)

Form of Warrant (Filed With SEC on December 20, 2019)

Form of Purchase Agreement (Filed With SEC on December 20, 2019)

Form of Warrant (Filed With SEC on December 9, 2019)

Form of Purchase Agreement (Filed With SEC on December 9, 2019)

Exclusive License Agreement (the License Agreement) with Copernicus Therapeutics, Inc (Filed With SEC on November 14, 2019)

Form of Warrant (Filed With SEC on June 4, 2019)

Amendment to Convertible Loan Agreements (Filed With SEC on June 4, 2019)

Chairman Agreement between the Company and Mark Sieczkarek dated as of April 23, 2019 (Filed With SEC on April 29, 2019)

Memorandum of Understanding between Wize Pharma Ltd. and Resdevco, Research and Development Ltd. dated February 24, 2019 (Filed With SEC on April 1, 2019)

Amendment to Convertible Loan Agreements (Filed With SEC on March 4, 2019)

Wize Pharma, Inc. (59)